Health systems are under growing pressure to improve patient outcomes while coping with staffing shortages and rising costs. Healthleap, a San Francisco-based clinical AI company, aims to help by screening hospitalized patients for conditions that often go undiagnosed, such as malnutrition. The platform operates within the electronic health record, flagging at-risk patients earlier in their stay.
The company announced last week that it has raised $38 million in combined seed and Series A funding. The round was led by Sequoia Capital, with participation from First Round Capital and Hummingbird Ventures. Healthleap plans to use the capital to expand its screening technology beyond malnutrition to additional conditions, including congestive heart failure, aspiration pneumonia, delirium, pressure ulcers, and certain hospital-acquired infections.
With this funding, the startup is positioning itself to help hospitals catch more overlooked conditions before they escalate, potentially reducing complications and costs. The announcement comes as health systems increasingly turn to AI tools that integrate directly into clinical workflows rather than adding extra steps for providers.